ALPA

Alpa Laboratories Share Price

 

 

Start SIP in ALPA

Start SIP

Performance

  • Low
  • ₹81
  • High
  • ₹85
  • 52 Week Low
  • ₹75
  • 52 Week High
  • ₹137
  • Open Price₹84
  • Previous Close₹83
  • Volume50,971

Investment Returns

  • Over 1 Month -8.91%
  • Over 3 Month -14.47%
  • Over 6 Month -16.73%
  • Over 1 Year -31.5%

Smart Investing Starts Here Start SIP with Alpa Laboratories for Steady Growth!

Invest Now

Alpa Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 9.2
  • PEG Ratio
  • -0.9
  • Market Cap Cr
  • 171
  • P/B Ratio
  • Average True Range
  • 4.43
  • EPS
  • 8.87
  • Dividend Yield
  • 0
  • MACD Signal
  • -2.04
  • RSI
  • 46.34
  • MFI
  • 69.33

Alpa Laboratories Financials

Alpa Laboratories Technicals

EMA & SMA

Current Price
₹81.31
-1.61 (-1.94%)
pointer
  • Bearish Moving Average 14
  • Bullish Moving Average 2
  • 20 Day
  • ₹82.30
  • 50 Day
  • ₹85.86
  • 100 Day
  • ₹90.60
  • 200 Day
  • ₹95.96

Resistance and Support

82.24 Pivot Speed
  • R3 88.34
  • R2 86.62
  • R1 83.96
  • S1 79.58
  • S2 77.86
  • S3 75.20

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Alpa Laboratories has an operating revenue of Rs. 111.44 Cr. on a trailing 12-month basis. An annual revenue growth of 10% is good, Pre-tax margin of 23% is great, ROE of 11% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 72 which is a FAIR score but needs to improve its earnings, a RS Rating of 26 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D- which indicates heavy supply, Group Rank of 41 indicates it belongs to a fair industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Alpa Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-14 Quarterly Results
2025-08-13 Quarterly Results & A.G.M.
2025-05-28 Audited Results
2025-02-13 Quarterly Results & Others To consider other business matters.
2024-11-14 Quarterly Results

Alpa Laboratories F&O

Alpa Laboratories Shareholding Pattern

57.29%
0.35%
37.15%
5.21%

About Alpa Laboratories

  • NSE Symbol
  • ALPA
  • BSE Symbol
  • 532878
  • Managing Director
  • Mr. Paresh Chawla
  • ISIN
  • INE385I01010

Similar Stocks to Alpa Laboratories

Alpa Laboratories FAQs

Alpa Laboratories share price is ₹81 As on 07 December, 2025 | 06:24

The Market Cap of Alpa Laboratories is ₹171.1 Cr As on 07 December, 2025 | 06:24

The P/E ratio of Alpa Laboratories is 9.2 As on 07 December, 2025 | 06:24

The PB ratio of Alpa Laboratories is 1 As on 07 December, 2025 | 06:24

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23